Amilpar - Press Release

News provided by

Amilpar

Jan 12, 2010, 05:14 ET

RIO DE JANEIRO, Jan. 12 /PRNewswire-FirstCall/ -- Amilpar (BOVESPA: AMIL3, Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3 SA), the largest managed care organization in Brazil, in accordance with CVM (Brazilian Securities and Exchange Commission) Instruction 358/02, informs that was approved in Board Meeting held today, the 1st Issuance of Debentures for public distribution with restricted selling efforts (according to CVM Instruction 476/09), with the objective of increase Company's cash position after the acquisition of Medial Saude S.A. control, under the following terms and conditions:

    Total Amount: R$ 300 million
    Term: 360 days, with the option of anticipating redemption after 180 days
    Remuneration: 109.75% of CDI (average interbank deposit rate in Brazil)
    Issuance: January 26, 2010
    Coordinators: Banco Itau BBA S.A. e HSBC CTVM S.A.

    To access the .pdf version, visit our website at www.amilpar.com.br/ir.

    IR Contacts:
    Investor Relations
    Phone.: +55 (21) 3805-1155
    E-mail: [email protected]
    www.amilpar.com.br/ir

SOURCE Amilpar

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED